Collen D - Search Results

1

Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.

Topol EJ, Califf RM, George BS, Kereiakes DJ, Rothbaum D, Candela RJ, Abbotsmith CW, Pinkerton CA, Stump DC, Collen D, et al. Topol EJ, et al. Among authors: collen d. Circulation. 1988 May;77(5):1100-7. doi: 10.1161/01.cir.77.5.1100. Circulation. 1988. PMID: 2966017 Clinical Trial.

2

Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group.

Stump DC, Califf RM, Topol EJ, Sigmon K, Thornton D, Masek R, Anderson L, Collen D. Stump DC, et al. Among authors: collen d. Circulation. 1989 Nov;80(5):1222-30. doi: 10.1161/01.cir.80.5.1222. Circulation. 1989. PMID: 2509104

3

Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.

Lijnen HR, Stump DC, Collen DC. Lijnen HR, et al. Among authors: collen dc. Semin Thromb Hemost. 1987 Apr;13(2):152-9. doi: 10.1055/s-2007-1003486. Semin Thromb Hemost. 1987. PMID: 3114883 Review. No abstract available.

4

Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction.

Sane DC, Stump DC, Topol EJ, Sigmon KN, Kereiakes DJ, George BS, Mantell SJ, Macy E, Collen D, Califf RM. Sane DC, et al. Among authors: collen d. Thromb Haemost. 1991 Mar 4;65(3):275-9. Thromb Haemost. 1991. PMID: 1904653

5

Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.

Eisenberg PR, Jaffe AS, Stump DC, Collen D, Bovill EG. Eisenberg PR, et al. Among authors: collen d. Circulation. 1990 Oct;82(4):1159-68. doi: 10.1161/01.cir.82.4.1159. Circulation. 1990. PMID: 2119264

6

Monitoring of hemostasis parameters during coronary thrombolysis with recombinant tissue-type plasminogen activator.

Stump DC, Topol EJ, Chen AB, Hopkins A, Collen D. Stump DC, et al. Among authors: collen d. Thromb Haemost. 1988 Apr 8;59(2):133-7. Thromb Haemost. 1988. PMID: 2455358

7

Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasis.

Flameng W, Vanhaecke J, Stump DC, Van de Werf F, Holmes W, Guenzler WA, Flohe L, Collen D. Flameng W, et al. Among authors: collen d. J Am Coll Cardiol. 1986 Jul;8(1):118-24. doi: 10.1016/s0735-1097(86)80101-2. J Am Coll Cardiol. 1986. PMID: 3086416 Free article.

8

Synergism of thrombolytic agents in vivo.

Collen D, Stassen JM, Stump DC, Verstraete M. Collen D, et al. Circulation. 1986 Oct;74(4):838-42. doi: 10.1161/01.cir.74.4.838. Circulation. 1986. PMID: 3093116

9

Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.

Collen D, De Cock F, Demarsin E, Lijnen HR, Stump DC. Collen D, et al. Thromb Haemost. 1986 Aug 20;56(1):35-9. Thromb Haemost. 1986. PMID: 3095946

10

Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents.

Collen D, Stump DC, Van de Werf F. Collen D, et al. Am Heart J. 1986 Nov;112(5):1083-4. doi: 10.1016/0002-8703(86)90323-6. Am Heart J. 1986. PMID: 3096127 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

811 results

Search Page